FDA says Glaxo drug fails to control bleeding

Wednesday, May 28, 2008 - 11:21 in Health & Medicine

WASHINGTON (AP) -- An experimental drug from GlaxoSmithKline does not significantly lower bleeding in patients with a rare blood disorder, according to the Food and Drug Administration....

Read the whole article on AP Health

More from AP Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net